High-dose chest CT exams were performed significantly more frequently during the Covid-19 pandemic to diagnose and treat patients. While critical for patient care, there are concerns about the potential increase in cancer risk linked with this ionizing radiation exposure. Based on the radiation dose, age, sex, and organ exposure, this study examines the cancer risk linked to high-dose thorax CT during the pandemic in Albania. This study is to evaluate the possible cancer risk associated with high-dose CT exams of the thorax for Covid patients. As a method for calculating the incidence of cancer linked to radiation exposure, the idea of Lifetime Attributable Risk (LAR) is investigated through data collection from Covid 19 patient for the period 2020 -2022. The study's methodology includes a thorough analysis of radiation exposure from CT scans, with a particular emphasis on the risks associated with cancer from thorax imaging techniques. The cancer risks significantly increased linearly with radiation dose of CT scans, with the highest risks for doses greater than 50 mSv. The lifetime attributable risk (LAR) of cancer for adults following CT scans was inordinately increased. This study also investigates how the Covid-19 pandemic has affected the need for and frequency of thoracic CT scans, considering the increasing use of imaging in the diagnosis and monitoring of respiratory diseases during this global health emergency. The results of this study emphasize how crucial it is to weigh the possible long-term hazards of radiation-induced cancer against the diagnostic advantages of high-dose thoracic CT scans. Using the patient's age, sex, and effective dose value, the risk factors from BEIR VII tables for more than 2000 patients, analyzing other complex factors that contribute to the risk of cancer, we found there is a low cancer risk estimation considering as an important factor the age of patients.

1. C. Huang et al., “Clinical features of patients infected with 2019 novel coronavirus in Wuhan,” Lancet, vol. 395, no. 10223, pp. 497 – 506, Feb. 2020.
   DOI: 10.1016/s0140-6736(20)30183-5
   PMid: 31986264
   PMCid: PMC7159299
2. Y. Yang et al., “Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections,” deposited at medRxiv, Feb. 17, 2020.
   DOI: 10.1101/2020.02.11.20021493
3. T. Ai et al., “Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease (COVID-19) in China: “A Report of 1014 Cases,” Radiology, vol. 296, no. 2, pp. E32 – E40, Aug. 2020.
   DOI: 10.1148/radiol.2020200642
   PMid: 32101510
   PMCid: PMC7233399
4. D. Caruso et al., “Chest CT Features of COVID-19 in Rome. Italy,” Radiology,vol. 296, no. 2, pp. E79 – E85, Aug. 2020.
   DOI: 10.1148/radiol.2020201237
   PMid: 32243238
   PMCid: PMC7194020
5. Y. Fang et. al., “Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR,”Radiology, vol. 296, no. 2, pp. E115 – E117, Aug. 2020.
   DOI: 10.1148/radiol.2020200432
   PMid: 32073353
   PMCid: PMC7233365
6. J. P. Kanne, B. P. Little, J. H. Chung, B. M. Elicker, L. H. Ketai, “Essentials for Radiologists on COVID-19: An Update- Radiology Scientific Expert Panel,” Radiology,vol. 296, no. 2, pp. E113 – E114, Aug. 2020.
   DOI: 10.1148/radiol.2020200527
   PMid: 32105562
   PMCid: PMC7233379
7. M. P. Revel et al., “European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI). COVID-19 patients and the radiology department - advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI),” Eur. Radiol., vol. 30, no. 9, pp. 4903 – 4909, Sep. 2020.
   DOI: 10.1007/s00330-020-06865-y
   PMid: 32314058
   PMCid: PMC7170031
8. N. Sverzellati et al., “Integrated Radiologic Algorithm for COVID-19 Pandemic,” J. Thorac. Imaging, vol. 35, no 4, pp. 228 – 233, Jul. 2020.
   DOI: 10.1097/RTI.0000000000000516
   PMid: 32271278
   PMCid: PMC7253044
9. Z. Kang, X. Li, S. Zhou, “Recommendation of low-dose CT in the detection and management of COVID-2019,” Eur. Radiol.,vol. 30, no. 8, pp. 4356 – 4357, Aug. 2020.
   DOI: 10.1007/s00330-020-06809-6
   PMid: 32193637
   PMCid: PMC7088271
10. C Ghetti, O. Ortenzia, F. Palleri, M. Sireus, “Definition of Local Diagnostic Reference Levels in a Radiology DepartmentUsing a Dose Tracking Software,” Radiat. Prot. Dosimetry, vol. 175, no. 1, pp. 38 – 45, Jun. 2017.
    DOI: 10.1093/rpd/ncw264
    PMid: 27614299
11. F. Palorini, D. Origgi, C. Granata, D. Matranga, S. Salerno, “Adult exposures from MDCT including multiphase studies: first Italian nationwide survey,” Eur. Radiol., vol. 24, no. 2, pp. 469 – 483, Feb. 2014.
    DOI: 10.1007/s00330-013-3031-7
    PMid: 24121713
12. N. Hyka, D. Xhako, G. Halilaj, F. Nela, “How chest CT radiation dose of patients with confirmed COVID-19 will impact the cancer risk in the future,” Phys. Med., vol. 92, suppl. S1, pp. S230 – S231, Dec. 2021.
13. D. Xhako, N. Hyka, S. Hoxhaj, E. Spahiu, P. Malkaj, “An Overview of Protocol for Quality Control Tests for Diagnostic Radiology Applied By Albmedtech,” J. Jilin University (Engineering and Technol. Edition), vol. 42, no. 11, pp. 72 – 84, Nov. 2023.
    DOI: 10.5281/zenodo.10081328
14. N. Hyka, D. Xhako, K. Sallabanda, P. Malkaj, “Using Deep Convolutional Neural Network to Create a DCNN Model for Brain Tumor Detection,” Eur. Chem. Bull., vol. 12, spec. issue 7, pp. 4979 – 4989, Jul. 2023.
    DOI: 10.48047/ecb/2023.12.si7.430